Titlebook: Lymphohaematopoietic Growth Factors in Cancer Therapy II; Roland Mertelsmann Conference proceedings 1992 Springer-Verlag Berlin Heidelberg

frustrate

書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II影響因子(影響力)




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II影響因子(影響力)學科排名




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II網(wǎng)絡(luò)公開度




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II網(wǎng)絡(luò)公開度學科排名




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II被引頻次




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II被引頻次學科排名




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II年度引用




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II年度引用學科排名




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II讀者反饋




書目名稱Lymphohaematopoietic Growth Factors in Cancer Therapy II讀者反饋學科排名

獎牌

OPINE

Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytesrequired to increase response rates and to improve the quality of tumour regression. The beneficial effects are to a great extent adoptive, as strongly suggested by the study of antitumour responses in immuno-depleted animals; the critical effectors of the antitumour response are the transfused cells.

Abominate

Clinical Studies with Interleukin-2: An Overviewmone intimately involved in the induction and sustenance of virtually all of the immune responses of T cells. After the discovery of the genetic sequence in 1983, production of rh-IL-2 on a large-scale basis became possible, allowing extensive clinical testing [2–4].

Synchronism

考博

lambaste

Clinical Trials with Local Administration of Lymphopoietic Growth Factorsaction mechanisms both . and . [1]. Efforts have, therefore, been made to use ILs to modulate immune responses. This approach has been rendered easier by recombinant DNA technology, which has made several ILs available in unlimited amounts.

Fresco

Clinical Trials with Interleukin-2. The Rome Experiencestitute of Rome, partially in collaboration with the Laboratory of Haematology and Oncology of the Italian National Institute of Health and the Department of Haematology of “La Sapienza” University, Rome.

ZEST

BOOST

Overview: 978-3-642-77803-2978-3-642-77801-8